Medical Blog About Treatment Abroad

Imagine a treatment that boosts your own immune response to fight lung cancer with precision, causing virtually no side effects while you maintain your daily routine. Dendritic cell therapy offers this possibility to patients at any cancer stage, showing effectiveness rates of 50-65% across various cancer types. With lung cancer affecting 226,650 new...

Esophageal cancer is one of the twenty most widespread cancer types. The disease can develop at any age, but most often it is diagnosed over the age of 60, when treatment options are already somewhat limited by the patient's chronic conditions. Patients who undergo treatment in Germany have a chance to significantly increase...

In recent years, doctors in developed countries have increasingly used immunotherapy treatment for leukemia. Healthcare professionals in Germany use innovative drugs that help cope with even refractory and relapsing forms of leukemia. Immunotherapy is mainly used for acute lymphocytic leukemia.

Dendritic cell prostate cancer treatment represents a groundbreaking immunotherapy approach, recognized by the 2011 Nobel Prize in Physiology or Medicine, awarded to Ralph Steinman. This innovative method can be prescribed to men of all ages and at any stage of prostate cancer, serving as an effective addition to standard treatment....

Thyroid cancer is one of the most rapidly growing endocrine malignancies worldwide. In Europe, the annual incidence reaches 8.3 cases per 100,000 population, while the mortality remains relatively low at 0.33 per 100,000. This situation reflects the effectiveness of modern diagnostic tools and treatment options, as well as the generally...

Bladder cancer is one of the most common cancers worldwide, affecting both men and women, though men are significantly more likely to be diagnosed. According to the U.S. National Cancer Institute, an estimated 84,870 new cases of bladder cancer have been diagnosed in the United States in 2024 alone, with approximately 17,420 related...

Cervical cancer affects approximately 660,000 women worldwide each year, making it the fourth most common cancer among women globally. While early detection typically offers excellent cure rates, advanced cases require innovative treatment approaches. Dendritic cell therapy represents a promising personalized immunotherapy...

Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease that primarily targets synovial joints, leading to inflammation, swelling, pain, and eventual joint deformity if left untreated. It affects about 0.5% to 1% of the global population, with women being two to three times more likely to develop the disease than men.